Perfil del autor: Vallejo Vaz, Antonio Javier
Datos institucionales
Nombre | Vallejo Vaz, Antonio Javier |
Departamento | Medicina |
Área de conocimiento | Medicina |
Categoría profesional | Beatriz Galindo (Investigador distinguido) |
Correo electrónico | Solicitar |
Estadísticas
-
Nº publicaciones
20
-
Nº visitas
1378
-
Nº descargas
2910
Publicaciones |
---|
Artículo
Fungal microbiota in newborn infants with and without respiratory distress syndrome
(Public Library Science, 2024)
Background Pneumocytis jirovecii infection in preterm newborns has recently been associated with neonatal respiratory ... |
Artículo
Overview of a collaborative global effort to address the burden of familial hypercholesterolaemia
(Elsevier, 2024)
This is an overview of the EAS Familial Hypercholesterolaemia (FH) Studies Collaboration (FHSC) global consortium and ... |
Artículo
Improving the Detection of Potential Cases of Familial Hypercholesterolemia: Could Machine Learning Be Part of the Solution?
(Wiley, 2024)
BACKGROUND: Familial hypercholesterolemia (FH), while highly prevalent, is a significantly underdiagnosed monogenic ... |
Artículo
Impact of the first wave of the COVID‑19 pandemic on non‑COVID inpatient care in southern Spain
(NATURE PUBLISHING GROUP, 2023)
We assessed the impact of the first wave of COVID-19 pandemic on non-COVID hospital admissions, non-COVID mortality, factors ... |
Tesis Doctoral
Grasa pancreática, función endotelial y remodelado endotelial en varones hipertensos con y sin síndrome metabólico
(2022)
El papel de la grasa pancreática en pacientes con hipertensión arterial (HTA) esencial y su relación con otras formas de ... |
Artículo
Implications of ACC/AHA Versus ESC/EAS LDL‑C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
(Springer, 2022)
Purpose Low-density lipoprotein cholesterol (LDL-C) recommendations difer between the 2018 American College of Cardi ... |
Artículo
Cerebrovascular Disease and Statins
(Frontiers Media, 2021)
Elevated low-density lipoprotein-cholesterol (LDL-C) is a causal factor for the development of atherosclerotic cardiovascular ... |
Artículo
Effect of computerised, knowledge-based, clinical decision support systems on patient-reported and clinical outcomes of patients with chronic disease managed in primary care settings: a systematic review
(BMJ Publishing Group, 2021)
Objectives Chronic diseases are the leading cause of disability globally. Most chronic disease management occurs in primary ... |
Artículo
LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial
(Elsevier, 2021)
Background and aims: Trial evidence for the benefits of cholesterol-lowering is limited for familial hypercho lesterolemia ... |
Artículo
A meta-analysis of medications directed against PCSK9 in familial hypercholesterolemia
(Elsevier Ireland, 2021)
Background and aims Several medications targeting PCSK9 reduce LDL-cholesterol (LDL-C) in heterozygous familial ... |
Artículo
Epidemiología clínica y medicina interna: una asociación simbiótica
(2021)
En el contexto de la biomedicina del siglo XXI, el internista continúa siendo uno de los principales vertebradores de la ... |
Artículo
Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
(Lippincott, Williams & Wilkins, 2020)
Purpose of review This review explores the concepts of monogenic and the so-called polygenic familial hypercholesterolemia ... |
Artículo
Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab
(Oxford University Press, 2020)
Aims: Guidelines recommend targeting non-high-density lipoprotein cholesterol to reduce cardiovascular risk. We assessed ... |
Artículo
Triglycerides and residual risk
(Lippincott, Williams & Wilkins, 2020)
Purpose of review: To review the recent evidence from observational/genetic/interventional studies addressing triglycerides ... |
Artículo
Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome
(Oxford University Press, 2017)
BACKGROUND Preeclampsia (PE) is a hypertensive disorder of pregnancy characterized by hypertension and proteinuria. The ... |
Tesis Doctoral
Efecto del tratamiento con presión positiva contínua en la vía aérea (CPAP) sobre distintos factores de riesgo vascular y marcadores de función endotelial y daño celular en pacientes con síndrome de apnea-hipopnea obstructiva del sueño
(2016)
Introducción: El síndrome de apnea-hipopnea obstructiva del sueño (SAOS) provoca episodios repetidos de hipoxemia-reoxigenación ... |
Artículo
Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP
(Public Library of Science, 2015)
Study objectives This study tries to assess the endothelial function in vivo using flow-mediated dilatation (FMD) and ... |
Artículo
Maternal Body-Mass Index and Cord Blood Circulating Endothelial Colony-Forming Cells
(Elsevier, 2014)
Objective Endothelial colony-forming cells (ECFCs) are a subset of circulating endothelial progenitor cells that are ... |
Artículo
Role of Circulating Cell-free DNA Levels in Patients With Severe Preeclampsia and HELLP Syndrome
(Oxford University Press, 2013)
BACKGROUND Increased plasma levels of circulating cell-free DNA (c-f DNA) have been recently described in diseases related ... |
Artículo
Olive oil polyphenols decrease blood pressure and improve endothelial function in young women with mild hypertension
(Oxford University Press, 2012)
Background: Olive oil polyphenols have been associated with several cardiovascular health benefits. This study aims to ... |